CN103284945A - Preparation method of pre-filled dexmedetomidine hydrochloride injection - Google Patents

Preparation method of pre-filled dexmedetomidine hydrochloride injection Download PDF

Info

Publication number
CN103284945A
CN103284945A CN2013102159380A CN201310215938A CN103284945A CN 103284945 A CN103284945 A CN 103284945A CN 2013102159380 A CN2013102159380 A CN 2013102159380A CN 201310215938 A CN201310215938 A CN 201310215938A CN 103284945 A CN103284945 A CN 103284945A
Authority
CN
China
Prior art keywords
injection
filled
dexmedetomidine hydrochloride
preparation
hydrochloride injection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2013102159380A
Other languages
Chinese (zh)
Inventor
朱义
王一茜
梁臻
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sichuan Baili Pharmaceutical Co Ltd
Original Assignee
Sichuan Baili Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan Baili Pharmaceutical Co Ltd filed Critical Sichuan Baili Pharmaceutical Co Ltd
Priority to CN2013102159380A priority Critical patent/CN103284945A/en
Publication of CN103284945A publication Critical patent/CN103284945A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a preparation method of a pre-filled dexmedetomidine hydrochloride injection. The preparation method of the pre-filled dexmedetomidine hydrochloride injection comprises the following steps of: A, preparing 80% of prescribed dose of water for injection, adding the prescribed dose of dexmedetomidine hydrochloride, stirring to dissolve for 5-8 minutes, then adding the water for injection to full dose, carrying out convection, and stirring and dissolving for 8-10 minutes; B, filtering a solution obtained by step A by virtue of a filter, and detecting an intermediate; and C, carrying out nitrogen filling, prefilling, encapsulation and sterilization on a solution obtained by step B, thus the pre-filled dexmedetomidine hydrochloride injection is obtained. The preparation method of the pre-filled hydrochloric acid dexmedetomidine injection has the advantages that concept is skilful, operation is simple, the problem that the dexmedetomidine hydrochloride injection is polluted in clinical application and inconvenient to use can be effectively solved, and rapidity and safety of an operation process can be guaranteed.

Description

A kind of preparation method of pre-filled dexmedetomidine hydrochloride injection
Technical field
The invention belongs to technical field of pharmaceutical chemistry, relate to a kind of preparation method of pre-filled dexmedetomidine hydrochloride injection.
Background technology
Dexmedetomidine hydrochloride, chemical name (+)-4-(S)-[1-(2,3-3,5-dimethylphenyl) ethyl]-the 1H-imidazole hydrochloride, be a kind of α 2-adrenoceptor agonists, have sedation.
The dexmedetomidine hydrochloride injection is the sterile water solution of dexmedetomidine hydrochloride.This product is colourless or almost colourless clear liquid, is applicable to beginning intubate during the Intensive Care Therapy treatment and uses respirator patient's calmness, is applicable to before operation and other operation or ongoing non-tracheal intubation patient's calmness.
At present, the dexmedetomidine hydrochloride injection all adopts the mode of interim preparation before using in clinical use, increased the use link, has the possibility of polluting, and in the part operation, has increased the operating time, fails to embody the characteristics of clinical quick and safe.
Summary of the invention
The objective of the invention is at the deficiencies in the prior art, a kind of preparation method of pre-filled dexmedetomidine hydrochloride injection is provided.This preparation method is skillfully constructed, and is simple to operate, can effectively solve the dexmedetomidine hydrochloride injection and have pollution, awkward problem in clinical use, guarantees quick, safety in the operation process.
For achieving the above object, the technical solution adopted for the present invention to solve the technical problems is:
A kind of preparation method of pre-filled dexmedetomidine hydrochloride injection may further comprise the steps:
A, get the water for injection of recipe quantity 80%, add the dexmedetomidine hydrochloride of recipe quantity, stirring and dissolving 5-8 minute, add to the full amount of water for injection convection current, stirring and dissolving 8-10 minute again;
B, the solution of getting steps A filter through filter, detect intermediate;
C, get step B solution through filling the embedding of nitrogen pre-filled, sterilization, namely get pre-filled dexmedetomidine hydrochloride injection.
As optimal way, in the steps A, the temperature of described water for injection is 60-65 ℃.
As optimal way, among the step B, described filter is the 0.22um filter.
As optimal way, among the step C, described sterilization is pressure sterilizing 15-30min under the 117-121 ℃ of temperature.
The inventor is by a large amount of research, each processing step of the preparation method of dexmedetomidine hydrochloride injection and parameter are improved and optimized, through experiment many times, the discovery that we are surprised: when the processing step that adopts the present invention to put down in writing and parameter, this preparation method is done as a whole, obtained best technique effect, effectively the defective that exists in the prior art that solves is optimized each index of product.
Beneficial effect of the present invention is: the present invention is skillfully constructed, and is simple to operate, can effectively solve the dexmedetomidine hydrochloride injection and have pollution, awkward problem in clinical use, guarantees quick, safety in the operation process.
The specific embodiment
Disclosed all features in this description, or the step in disclosed all methods or the process except mutually exclusive feature and/or step, all can make up by any way.
Embodiment 1:
1, clean liquid mixing system before the dosing: equipment such as Agitation Tank, pipeline wash three times with water for injection before the preparation, and discharging is clean.
2, feed intake, prepare: the water for injection (65 ℃) of 1. getting full dose 80%.2. the dexmedetomidine hydrochloride that adds recipe quantity.3. stirring and dissolving is 5 minutes.4. add to the full amount of water for injection.5. convection current, stirring and dissolving 10 minutes.6. the 0.22um filter filters.7. detect intermediate.
3, intermediate detects: detect by the intermediate quality standard.
4, pre-filled container arrangement.
5, the dosing technology process is as follows: filter, fill nitrogen, fill, fill nitrogen, top plug seals
6, the leak detection of getting on the bus, sterilize
Sterilising temp is 121 ℃, and the time is 15 minutes.
7, Jian Lou vacuum must-more than the 80Kpa, the leak detection time is more than 10 minutes.
8, lamp inspection
Semi-finished product after the sterilization adopt daylight lamp, under black background, look with visual inspection.
Thought is concentrated during lamp inspection, every medicinal liquid up and down gently upset check, can foreign body, outward appearance and other inspection item should be up to specification.
9, packing inspection warehouse-in.
 
Embodiment 2:
1, clean liquid mixing system before the dosing: equipment such as Agitation Tank, pipeline wash three times with water for injection before the preparation, and discharging is clean.
2, feed intake, prepare: the water for injection (60 ℃) of 1. getting full dose 80%.2. the dexmedetomidine hydrochloride that adds recipe quantity.3. stirring and dissolving is 8 minutes.4. add to the full amount of water for injection.5. convection current, stirring and dissolving 8 minutes.6. the 0.22um filter filters.7. detect intermediate.
3, intermediate detects: detect by the intermediate quality standard.
4, pre-filled container arrangement.
5, the dosing technology process is as follows: filter, fill nitrogen, fill, fill nitrogen, top plug seals
6, the leak detection of getting on the bus, sterilize
Sterilising temp is 117 ℃, time 30min.
7, Jian Lou vacuum must-more than the 80Kpa, the leak detection time is more than 10 minutes.
8, lamp inspection
Semi-finished product after the sterilization adopt daylight lamp, under black background, look with visual inspection.
Thought is concentrated during lamp inspection, every medicinal liquid up and down gently upset check, can foreign body, outward appearance and other inspection item should be up to specification.
9, packing inspection warehouse-in.

Claims (4)

1. the preparation method of a pre-filled dexmedetomidine hydrochloride injection is characterized in that, may further comprise the steps:
A, get the water for injection of recipe quantity 80%, add the dexmedetomidine hydrochloride of recipe quantity, stirring and dissolving 5-8 minute, add to the full amount of water for injection convection current, stirring and dissolving 8-10 minute again;
B, the solution of getting steps A filter through filter, detect intermediate;
C, get step B solution through filling the embedding of nitrogen pre-filled, sterilization, namely get pre-filled dexmedetomidine hydrochloride injection.
2. the preparation method of a kind of pre-filled dexmedetomidine hydrochloride injection as claimed in claim 1, it is characterized in that: in the steps A, the temperature of described water for injection is 60-65 ℃.
3. the preparation method of a kind of pre-filled dexmedetomidine hydrochloride injection as claimed in claim 1, it is characterized in that: among the step B, described filter is the 0.22um filter.
4. the preparation method of a kind of pre-filled dexmedetomidine hydrochloride injection as claimed in claim 1, it is characterized in that: among the step C, described sterilization is pressure sterilizing 15-30min under the 117-121 ℃ of temperature.
CN2013102159380A 2013-06-03 2013-06-03 Preparation method of pre-filled dexmedetomidine hydrochloride injection Pending CN103284945A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2013102159380A CN103284945A (en) 2013-06-03 2013-06-03 Preparation method of pre-filled dexmedetomidine hydrochloride injection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2013102159380A CN103284945A (en) 2013-06-03 2013-06-03 Preparation method of pre-filled dexmedetomidine hydrochloride injection

Publications (1)

Publication Number Publication Date
CN103284945A true CN103284945A (en) 2013-09-11

Family

ID=49086843

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2013102159380A Pending CN103284945A (en) 2013-06-03 2013-06-03 Preparation method of pre-filled dexmedetomidine hydrochloride injection

Country Status (1)

Country Link
CN (1) CN103284945A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105168122A (en) * 2015-09-24 2015-12-23 辰欣药业股份有限公司 Dexmedetomidine hydrochloride injection and preparation process thereof
CN105534891A (en) * 2016-01-18 2016-05-04 南京正科医药股份有限公司 Dexmedetomidine hydrochloride injection
CN107028880A (en) * 2017-06-09 2017-08-11 安徽赛诺制药有限公司 A kind of production technology of dexmedetomidine hydrochloride parenteral solution
CN108578641A (en) * 2018-06-29 2018-09-28 无锡济民可信山禾药业股份有限公司 A kind of Prefilled preparation of clinical emergency treatment traditional Chinese medicine injection
US11786508B2 (en) 2016-12-31 2023-10-17 Bioxcel Therapeutics, Inc. Use of sublingual dexmedetomidine for the treatment of agitation
US11806429B2 (en) 2018-06-27 2023-11-07 Bioxcel Therapeutics, Inc. Film formulations containing dexmedetomidine and methods of producing them
US11890272B2 (en) 2019-07-19 2024-02-06 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101780033A (en) * 2009-12-21 2010-07-21 北京凯因科技股份有限公司 Pre-filled recombinant human interferon injection

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101780033A (en) * 2009-12-21 2010-07-21 北京凯因科技股份有限公司 Pre-filled recombinant human interferon injection

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
徐蓉蓉等: "右美托咪定药代动力学和药效动力学的研究进展", 《广东医学》, vol. 33, no. 8, 30 April 2012 (2012-04-30), pages 1037 - 1040 *
舒成仁等: "盐酸右美托咪定注射液在健康人体的药动学", 《医药导报》, vol. 30, no. 12, 31 December 2011 (2011-12-31), pages 1555 - 1558 *
蔡荣: "预灌装注射器简介", 《上海包装》, no. 2, 31 December 2006 (2006-12-31), pages 19 - 20 *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105168122A (en) * 2015-09-24 2015-12-23 辰欣药业股份有限公司 Dexmedetomidine hydrochloride injection and preparation process thereof
CN105168122B (en) * 2015-09-24 2018-11-27 辰欣药业股份有限公司 A kind of dexmedetomidine hydrochloride injection and its preparation process
CN105534891A (en) * 2016-01-18 2016-05-04 南京正科医药股份有限公司 Dexmedetomidine hydrochloride injection
US11786508B2 (en) 2016-12-31 2023-10-17 Bioxcel Therapeutics, Inc. Use of sublingual dexmedetomidine for the treatment of agitation
US11839604B2 (en) 2016-12-31 2023-12-12 Bioxcel Therapeutics, Inc. Use of sublingual dexmedetomidine for the treatment of agitation
US11931340B2 (en) 2016-12-31 2024-03-19 Bioxcel Therapeutics, Inc. Use of sublingual dexmedetomidine for the treatment of agitation
CN107028880A (en) * 2017-06-09 2017-08-11 安徽赛诺制药有限公司 A kind of production technology of dexmedetomidine hydrochloride parenteral solution
US11806429B2 (en) 2018-06-27 2023-11-07 Bioxcel Therapeutics, Inc. Film formulations containing dexmedetomidine and methods of producing them
CN108578641A (en) * 2018-06-29 2018-09-28 无锡济民可信山禾药业股份有限公司 A kind of Prefilled preparation of clinical emergency treatment traditional Chinese medicine injection
US11890272B2 (en) 2019-07-19 2024-02-06 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Similar Documents

Publication Publication Date Title
CN103284945A (en) Preparation method of pre-filled dexmedetomidine hydrochloride injection
CN201519335U (en) Anti-pollution structure of medial remaining needle positive pressure connector
CN103550143B (en) A kind of preparation method of levetiracetam injection
CN106428817B (en) The cillin bottle and cillin bottle dress water for injection that a kind of processing method of cillin bottle, processing obtain
CN102626409B (en) A kind of pharmaceutical composition containing 18 seed amino acids
CN102274170A (en) Method for preparing tinidazole and sodium chloride injection
CN103479522A (en) Method for preparing levofloxacin hydrochloride sodium chloride injection
CN102319203A (en) Preparation method of levofloxacin lactate and sodium chloride injection
CN104548278B (en) A kind of Enoxaparin Sodium tube sealing parenteral solution and preparation method thereof
CN106265499A (en) A kind of compound potassium dihydrogn phosphate pharmaceutical composition
CN103463013B (en) Preparation process of high-concentration compound amino acid injection
CN102836123A (en) Injection containing levetiracetam active ingredient and technology for preparing injection
CN102172346A (en) Production method of compound sodium lactate glucose injection capable of preventing yellowing
CN104084402B (en) Convenient injector
CN106692047A (en) Production technique of glucose injection
CN102319258A (en) 5 percent glucose substitution liquid and preparation method thereof
CN204133967U (en) The syringe of detachable core bar
CN103720649A (en) Method for preparing alanyl-glutamine injection
CN103371967A (en) Furosemide injection and preparation process thereof
CN102228459B (en) Sodium rabeprazole composition used for injection
CN103070823A (en) Aseptic packaging method of large volume injection
CN103239392B (en) Ornidazole injection preparation and preparation method
CN103463127A (en) Sodium acetate ringer injection and preparation method thereof
CN104224696A (en) Preparation method of aminomethylbenzoic acid injection
CN104666340A (en) Glycerin fructose sodium chloride injection and preparation process thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130911